North East and North Cumbria
ICS Formulary
 
back
13 Skin

Specials Recommended by the British Association of Dermatologists for Skin Disease

Most prescribing uses licensed medicines whose safety and efficacy are assured. For many common dermatological diseases including psoriasis and eczema, the range of licensed medicines is limited. As a result, Dermatology prescribing may rely significantly on unlicensed creams and ointments (known as ‘Specials’) containing tars, dithranol, salicylic acid, steroids and other active constituents in a range of concentrations and bases. This is of particular concern in primary care where lack of effective price controls and a mechanism to ensure independent scrutiny of product quality has increased costs and concern about standards. To address these concerns, and help optimise quality of care, adherence to the revised British Association of Dermatologists (BAD) list of preferred Specials (2018) is encouraged.

13-06-01 Other topical preparations for rosacea

Brimonidine Tartate 0.33% gel Mirvaso®
Formulary
  • For specialist initiation for the treatment of severe rosacea. Following specialist review of effectiveness, primary care can continue supply.
Link  MHRA Drug Safety Update (June 2017): Brimonidine gel (Mirvaso): risk of systemic cardiovascular effects; not to be applied to damaged skin
Link  MHRA Drug Safety Update (Nov 2016): Brimonidine gel (Mirvaso): risk of exacerbation of rosacea

Green View adult BNF  View SPC online  View childrens BNF
Ivermectin 1% cream Soolantra®
Formulary
  • For the treatment of papulopustular rosacea in patients as second line treatment in patient who have failed topical metronidazole.

Green View adult BNF  View SPC online  View childrens BNF